SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $3,760,253,505 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $2,047,516,314 | 10,629,822 |
| INSMED INC | INSM | COM PAR $.01 | $673,600,013 | 6,431,163 |
| BELITE BIO INC | BLTE | SPONSORED ADS | $456,588,244 | 3,077,219 |
| ABIVAX SA | ABVX | SPONSORED ADS | $348,215,205 | 3,621,583 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $234,333,729 | 6,747,300 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.